ENDRA Life Sciences Inc. — Key Metrics
5 years of history · ending 2020-12-31 · SEC EDGAR
Forensics
Three classic accounting-quality scores. F-Score (0-9, higher = better fundamentals); M-Score (>-1.78 flags possible manipulation); Z-Score (>2.99 = safe, <1.81 = distressed). Use together — single-score readings are noisy.
F-Score (Piotroski 0-9)
Turnover & Efficiency Analysis (days)
Expense Ratios
Working Capital Analysis
52-Week Range
Trailing Returns
ROIC vs WACC
EPS (Diluted)
—
Book Value Per Share
—
Free Cash Flow Per Share
—
OCF Per Share
—
Return on Equity↓-507.1pts
-196.6%
Return on Assets↑+418.4pts
-147.1%
Return on Invested Capital↓-310.7pts
-152.3%
Debt to Equity
—
Current Ratio↑+5788.5% +$8
8.32
Quick Ratio↑+6775.2% +$8
7.72
Asset Turnover↓-100.0% -$1
0.00
Days Sales Outstanding
0.00
Days Payables Outstanding
1648.29
Days Inventory On Hand
404.92
Cash Conversion Cycle
-1236.26
R&D / Revenue
76489.6%
Capex / Revenue
1619.7%
Working Capital↑+707.4% +$8M
$7M
Net Current Asset Value↑+656.1% +$8M
$7M
Invested Capital↑+902.1% +$8M
$7M
OCF / Net Income↑+93.3% +$0
0.92
FCF / Net Income↑+94.7% +$0
0.92
Accruals Ratio (Sloan)↑+286.3pts
-11.2%
Net Debt
—
Net Debt / EBITDA
—
Interest Coverage
-3125.71
Cash Coverage
-2230.35
Capex Coverage
-142.65
Tangible Common Equity↑+902.1% +$8M
$7M
TCE / Total Assets↑+263.9pts
81.8%
NOPAT↓-541.9% -$8M
$-9M
Cash ROIC↓-328.6pts
-181.4%
WC / Revenue
96776.4%
Capex / D&A
0.76
Reinvestment Rate↓-3.4pts
0.2%
Asset Growth vs Revenue Growth
99.4%
Book Value 5Y CAGR
—
Stock Price (FY-end)
$26K
Market Cap
—
P/B Ratio
—
P/TB Ratio
—
Enterprise Value
—
FCF Yield
—
Shareholder Yield
—
R&D Yield
—
Capex Yield
—
Shares Variation (YoY)
—
Beta (5Y)
0.85
Cost of Equity
8.8%
52W High
$75K
52W Low
$22K
Trailing Return 1Y
-60.5%
Trailing Return 5Y
—
F-Score (Piotroski)
3.00
Earnings Forecasts
Per-quarter consensus estimates + actuals + beat/miss surprise. Sourced from Finnhub (Wall Street consensus aggregation).
Source caveat: Finnhub free tier returns the consensus mean only — analyst high / low / dispersion + analyst counts require a paid plan. A "$5.00 consensus" line above could mean "20 analysts at exactly $5" (high conviction) or "10 at $5.50, 10 at $4.50" (split). Treat single-line consensus accordingly.